1. Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8
   Y Jiang et al, 2015, Oncogene CrossRef
2. Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
   Jialin Wang et al, 2021, PeerJ CrossRef
3. The Potential MicroRNA Diagnostic Biomarkers in Oral Squamous Cell Carcinoma of the Tongue
   Young-Nam Park et al, 2024, Current Issues in Molecular Biology CrossRef
4. The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)
   F Hakami et al, 2014, British Journal of Cancer CrossRef
5. The role of HOX genes in head and neck squamous cell carcinoma
   Christopher Platais et al, 2016, Journal of Oral Pathology & Medicine CrossRef
6. Bridging Links between Long Noncoding RNA HOTAIR and HPV Oncoprotein E7 in Cervical Cancer Pathogenesis
   Sweta Sharma et al, 2015, Scientific Reports CrossRef
7. Homeobox gene amplification and methylation in oral squamous cell carcinoma
   Maria Fernanda Setúbal Destro Rodrigues et al, 2021, Archives of Oral Biology CrossRef
8. Epigenetic repression of HOXB cluster in oral cancer cell lines
   Flávia Caló Aquino Xavier et al, 2014, Archives of Oral Biology CrossRef
9. An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy
   Wenpeng Cao et al, 2023, Aging CrossRef
10. miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer
    Tatiana N. Libório-Kimura et al, 2015, Oral Oncology CrossRef
11. PROX1 Gene is Differentially Expressed in Oral Cancer and Reduces Cellular Proliferation
    Maria F.S.D. Rodrigues et al, 2014, Medicine CrossRef
12. DMRforPairs: identifying Differentially Methylated Regions between unique samples using array based methylation profiles
    Martin A Rijlaarsdam et al, 2014, BMC Bioinformatics CrossRef
13. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma
    Rafaela de Barros e Lima Bueno et al, 2016, Tumor Biology CrossRef
14. Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme
    Yanxin Li et al, 2021, OncoTargets and Therapy CrossRef
15. Computational Search for Possible Mechanisms of 4‐Thiazolidinones Anticancer Activity: The Power of Visualization
    Oleg Devinyak et al, 2014, Molecular Informatics CrossRef
16. Identification of upregulated genes in oral squamous cell carcinomas
    Roberta C. Lessa et al, 2013, Head & Neck CrossRef
17. CEMP1 Induces Transformation in Human Gingival Fibroblasts
    Mercedes Bermúdez et al, 2015, PLOS ONE CrossRef
18. New insights in the clinical implication of HOXA5 as prognostic biomarker in patients with colorectal cancer
    Hamza Yaiche et al, 2021, Cancer Biomarkers CrossRef
19. Engrailed-2 promotes a malignant phenotype of esophageal squamous cell carcinoma through upregulating the expression of pro-oncogenic genes
    Yong Cao et al, 2020, PeerJ CrossRef
20. HOXA5 inhibits tumor growth of gastric cancer under the regulation of microRNA-196a
    Yingxin Wu et al, 2019, Gene CrossRef
21. Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro
    Kawaljit Kaur et al, 2024, Critical Reviews in Immunology CrossRef
22. HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target
    Fan Fan et al, 2022, Biomedicine & Pharmacotherapy CrossRef
23. Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients
    Marjanu Hikmah Elias et al, 2018, Cancer Reports CrossRef
24. Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level
    Konrad Dziobek et al, 2020, Current Pharmaceutical Biotechnology CrossRef